Chlamydia trachomatis infections in mammals, including humans, comprising administering intramuscularly, in a single dose, to a mammal requiring such treatment a composition comprising doxycycline or minocycline in a pharmaceutically acceptable vehicle that provides plasma concentrations of doxycycline or minocycline of at least about 0.1 micrograms per ml for a period of at least about 4-5 days."/> Single dose intramuscular treatment of chlamydia trachomatis infections
首页> 外国专利> Single dose intramuscular treatment of chlamydia trachomatis infections

Single dose intramuscular treatment of chlamydia trachomatis infections

机译:单剂肌内治疗沙眼衣原体感染

摘要

A method of treating Chlamydia trachomatis infections in mammals, including humans, comprising administering intramuscularly, in a single dose, to a mammal requiring such treatment a composition comprising doxycycline or minocycline in a pharmaceutically acceptable vehicle that provides plasma concentrations of doxycycline or minocycline of at least about 0.1 micrograms per ml for a period of at least about 4-5 days.
机译:一种在包括人在内的哺乳动物中治疗沙眼衣原体感染的方法,该方法包括对需要这种治疗的哺乳动物以肌内注射方式单剂量给药包含药学上可接受的强力霉素或米诺环素的组合物。载体提供至少每毫升至少约0.1微克多西环素或米诺环素的血浆浓度,持续至少约4-5天的时间。

著录项

  • 公开/公告号EP0337733A3

    专利类型

  • 公开/公告日1990-01-31

    原文格式PDF

  • 申请/专利权人 PFIZER INC.;

    申请/专利号EP19890303570

  • 发明设计人 GIBBS DAVID L.;

    申请日1989-04-11

  • 分类号A61K9/08;A61K31/65;

  • 国家 EP

  • 入库时间 2022-08-22 06:14:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号